NV

NVO

NYSE

Novo Nordisk A/S

Healthcare
Drug Manufacturers - General
Denmark
49.67USD
+0.90 (+1.85%)
Market Cap: 219.88B USD
NVO
49.67 +1.33(+2.75%)
1D
5D
1M
6M
YTD
1Y
5Y
ALL

Key Statistics

Valuation

Market Cap (USD)219.88B
Market Cap (Local)219.88B
P/E (TTM)11.82
P/S (TTM)4.40
MC/EBITDA8.02

Volume & Shares

Last Volume6.80M
Avg Vol (10D)7.75M
Avg Vol (30D)8.82M
Avg Vol (90D)12.76M
Shares Outstanding4.43B

Growth Indicators

Revenue TTM/Ann1.06
Net Income TTM/Ann1.19
EBITDA TTM/Ann1.15
Gross Profit TTM/Ann1.07
Operating Inc TTM/Ann1.16

Currency & Exchange

Trading CurrencyUSD
Financial CurrencyDKK
Trading/USD Rate1.00
Financial/USD Rate0.15
ExchangeNYSE

Momentum & Signals

Stock Momentum
Neutral
Industry Momentum
Neutral
Market Outperform
3mNeutral
6mModerate Underperformance
Forward Looking
3mNeutral / Uncertain
6mNeutral / Uncertain
Signal Correlation
Low

Annual

in DKKAmount
Revenue309.06B
Cost of Revenue58.79B
Gross Profit250.28B
Research & Development52.04B
Operating Income127.66B
Net Income102.43B
EBITDA156.73B

TTM

in DKKAmount
Revenue327.80B
Cost of Revenue59.50B
Gross Profit268.30B
Research & Development52.02B
Operating Income148.49B
Net Income121.96B
EBITDA179.89B